Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study

被引:12
|
作者
Song, M. [1 ]
Ware, R. [2 ]
Doan, T. N. [3 ]
Harley, D. [1 ]
机构
[1] Mater Res Inst Univ Queensland MRI UQ, Queensland Ctr Intellectual & Dev Disabil QCIDD, Room 233,Aubigny Pl,Raymond Terrace, South Brisbane, Qld 4101, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia
[3] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia
关键词
antipsychotics; challenging behaviour; cohort study; intellectual disability; problem behaviour; psychotropics;
D O I
10.1111/jir.12685
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background Longitudinal data on medication use in adults with intellectual disability (ID) are scarce. We describe the longitudinal use of and factors associated with psychotropic medication prescribing in adults with ID living in the Australian community. Methods Longitudinal data were obtained from adults with ID in the community in Queensland, Australia, between 1999 and 2015. Participant characteristics and medication use information were extracted from baseline questionnaires and health check booklets. Logistic regression was used to investigate the associations between participant characteristics and psychotropic medication use, commencement or cessation. Results Longitudinal data were available for 138 participants on 697 reviews. The proportion of participants prescribed psychotropic medications increased from 43% to 54% between 1999 and 2015. The rates of commencement and cessation of psychotropic medications between consecutive time periods ranged from 9% to 18% and 7% to 15%, respectively. Challenging behaviour was associated with psychotropic medication use (adjusted odds ratio = 4.1; 95% confidence interval: 2.1-7.9). Presence of challenging behaviour, either consistent or newly identified, was positively associated with ongoing use or commencement of psychotropic medications. Conclusions Psychotropic medications are commonly prescribed to adults with ID. Challenging behaviour is positively associated with ongoing use and commencement.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [31] PSYCHOTROPIC MEDICATION USE IN HUNTINTON'S DISEASE: A RETROSPECTIVE COHORT STUDY
    Andriessen, Ruben L.
    Oosterloo, Mayke
    Hollands, Angelique
    Linden, David E. J.
    De Greef, Bianca T. A.
    Leentjens, Albert F. G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A99 - A99
  • [32] Psychotropic medication use in Huntington's disease: A retrospective cohort study
    Andriessen, Ruben L.
    Oosterloo, Mayke
    Hollands, Angelique
    Linden, David E. J.
    de Greef, Bianca T. A.
    Leentjens, Albert F. G.
    PARKINSONISM & RELATED DISORDERS, 2022, 105 : 69 - 74
  • [33] Staff perceptions following a training programme about reducing psychotropic medication use in adults with intellectual disability: The need for a realistic professional practice framework
    Barratt, Macey
    Jorgensen, Mikaela
    Deb, Shoumitro
    Limbu, Bharati
    Donley, Mandy
    Buchholtz, Moira
    Smith, Victoria
    Wilson, Nathan
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2023, 36 (03) : 486 - 496
  • [34] STUDY ON THE USE OF ANTIPSYCHOTIC MEDICATION IN AN INTELLECTUAL DISABILITY (ID) COMMUNITY CASELOAD
    Thalitaya, Madhusudan Deepak
    Reynolds, Claire
    Ismail, Imadeldin
    PSYCHIATRIA DANUBINA, 2017, 29 : S578 - S583
  • [35] ASSOCIATIONS BETWEEN MEDICATION USE AND FALLS AMONG OLDER ADULTS WITH INTELLECTUAL DISABILITY IN IRELAND
    Foran, Sinead
    Dwyer, Maire O.
    McCarron, Mary
    Henman, Martin
    McCallion, Philip
    AGE AND AGEING, 2016, 45 : 12 - 12
  • [36] Audit on use of PRN (pro re nata) psychotropic medication for behavioural disturbance in individuals with intellectual disability in the community
    Dhandapani, Asha
    Soundararajan, Sathyan
    Jones, Claire
    BJPSYCH OPEN, 2021, 7 : S75 - S76
  • [37] Medication use among Australian adults with intellectual disability in primary healthcare settings: A cross-sectional study
    Doan, Tan N.
    Lennox, Nicholas G.
    Taylor-Gomez, Miriam
    Ware, Robert S.
    JOURNAL OF INTELLECTUAL & DEVELOPMENTAL DISABILITY, 2013, 38 (02): : 177 - 181
  • [38] Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study
    McMahon, M.
    Hatton, C.
    Bowring, D. L.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2020, 64 (11) : 834 - 851
  • [39] Psychotropic medication use among adolescent disaster survivors: a prospective cohort study
    Dorn, T
    Yzermans, CJ
    Kerssens, JJ
    ten Veen, PMH
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2004, 14 (04): : 70 - 70
  • [40] Psychotropic medication use in children and adolescents:: A study from France
    Sevilla-Dedieu, Christine
    Kovess-Masfety, Viviane
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (03) : 281 - 289